LAWSUITS FILED AGAINST PRA, CODX and IDEX - JAKUBOWITZ LAW PURSUES SHAREHOLDERS CLAIMS

In this article:

NEW YORK, NY / ACCESSWIRE / July 2, 2020 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies who purchased shares within the class periods listed below. Shareholders interested in representing the class of wronged shareholders have until the lead plaintiff deadline to petition the court. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. For more details and to speak with our firm without cost or obligation, follow the links below.

ProAssurance Corporation (PRA)

CONTACT JAKUBOWITZ ABOUT PRA: https://claimyourloss.com/securities/proassurance-corporation-loss-submission-form/?id=7740&from=1

Class Period: April 26, 2019 - May 7, 2020

Lead Plaintiff Deadline: August 17, 2020

The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (i) ProAssurance lacked adequate underwriting process and risk management controls necessary to set appropriate loss reserves in its Specialty P&C segment; (ii) ProAssurance failed to properly assess a large national healthcare account that experienced losses far exceeding the assumptions made when the account was underwritten; and (iii) as a result, ProAssurance was subject to materially heightened risk of financial loss and reserve charges.

Co-Diagnostics, Inc. (CODX)

CONTACT JAKUBOWITZ ABOUT CODX: https://claimyourloss.com/securities/co-diagnostics-inc-loss-submission-form/?id=7740&from=1

Class Period: February 25, 2020 - May 15, 2020

Lead Plaintiff Deadline: August 17, 2020

According to the filed complaint, Co-Diagnostics and its directors and officers (including PhD-level scientists who should know better) made continual, knowing, and willful misstatements about the Company's main product, a Covid-19 diagnostic test. These misstatements had the effect of pumping up the price of Co-Diagnostics' stock, while Company officers and directors exercised low-priced options and dumped their stock into the market. Co-Diagnostics' fraudulent misstatements displayed a disregard for basic scientific principles and caused investors to lose millions of dollars.

Ideanomics, Inc. (IDEX)

CONTACT JAKUBOWITZ ABOUT IDEX: https://claimyourloss.com/securities/ideanomics-inc-loss-submission-form/?id=7740&from=1

Class Period: March 20, 2020 - June 25, 2020

Lead Plaintiff Deadline: August 27, 2020

The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (i) Ideanomics' Mobile Energy Global Division in Qingdao, China (the "MEG Center") was not "a one million square foot EV expo center" as the Company had stated in press releases; (ii) the Company had been using doctored or altered photographs of the purported MEG Center in Qingdao; (iii) the Company's electric vehicle business in China was not performing nearly as strongly as Ideanomics had represented; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.

Jakubowitz Law is vigorous in pursuit of justice for shareholders who have been the victim of securities fraud. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
JAKUBOWITZ LAW
1140 Avenue of the Americas
9th Floor
New York, New York 10036
T: (212) 867-4490
F: (212) 537-5887

SOURCE: Jakubowitz Law



View source version on accesswire.com:
https://www.accesswire.com/596113/LAWSUITS-FILED-AGAINST-PRA-CODX-and-IDEX--JAKUBOWITZ-LAW-PURSUES-SHAREHOLDERS-CLAIMS

Advertisement